FDA Approves First-Ever Agent to Delay Type 1 Diabetes Onset

Norge Nyheter Nyheter

FDA Approves First-Ever Agent to Delay Type 1 Diabetes Onset
Norge Siste Nytt,Norge Overskrifter
  • 📰 Medscape
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 55%

🆕 FDAapproves the anti-CD3 monoclonal antibody teplizumab-mzwv to delay the onset of clinical type 1 diabetes in people aged 8 years and older who are at high risk for developing the condition. MedTwitter

"Today’s approval of a first-in-class therapy adds an important new treatment option for certain at-risk patients," said John Sharretts, MD, director of the Division of Diabetes, Lipid Disorders, andin the FDA's Center for Drug Evaluation and Research."The drug’s potential to delay clinical diagnosis of type 1 diabetes may provide patients with months to years without the burdens of disease.

The agent, which interferes with T-cell-mediated autoimmune destruction of pancreatic beta cells, is the first disease-modifying therapy for impeding progression of type 1 diabetes. It is administered by intravenous infusion once daily for 14 consecutive days. The specific indication is"to delay the onset of stage 3 type 1 diabetes in adults and pediatric patients 8 years and older who currently have stage 2 type 1 diabetes." In type 1 diabetes staging, adopted in 2015,with two or more islet autoantibodies with normoglycemia, stage 2 is beta-cell autoimmunity with dysglycemia yet asymptomatic, and stage 3 is the onset of symptomatic type 1 diabetes.

Stage 2 type 1 diabetes is associated with a nearly 100% lifetime risk of progression to clinical type 1 diabetes and a 75% risk of developing the condition within 5 years.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

Medscape /  🏆 386. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

FDA approves first treatment to delay onset of type 1 diabetes | CNNFDA approves first treatment to delay onset of type 1 diabetes | CNNA biologic therapy that delays the onset of type 1 diabetes received approval from the US Food and Drug Administration on Thursday.
Les mer »

FDA approves the sale of the first lab-grown meat in the USFDA approves the sale of the first lab-grown meat in the USUPSIDE Foods is just a few steps away from being able to market its lab-grown meat in the U.S. It now needs to solve the hurdle fo scaling up.
Les mer »

FDA approves lab-grown meat in historic US firstFDA approves lab-grown meat in historic US firstThe FDA says it is now ready to work with other 'firms developing cultured animal cell food and production processes,' signaling changes in agricultural meat production.
Les mer »

FDA approves lab-grown meat for the first timeFDA approves lab-grown meat for the first timeFor the first time, the Food and Drug Administration is giving the green light to meat grown in a laboratory. The agency said in a notice on Wednesday that a 'cultivated chicken' product made by Upside Foods is safe to eat.
Les mer »

FDA Approves First Lab Grown Meat Product For Human ConsumptionFDA Approves First Lab Grown Meat Product For Human ConsumptionThe FDA has approved a lab grown meat product from Upside Foods for human consumption, which now only needs USDA approval before being sold to customers.
Les mer »

FDA approves lab-grown meat produced by Berkeley companyFDA approves lab-grown meat produced by Berkeley companyBerkeley-based Upside Foods' 'cultured' chicken is closer to being sold in U.S. grocery stores after regulator agrees it's safe to eat.
Les mer »



Render Time: 2025-03-10 16:22:14